genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2009
Chronic lymphocytic leukemia
Insights
Biogen Idec and Facet—Following the Money
News
Special Report: Biogen Idec and Facet—Following the Money
Cancer
Facet Biotech Steps Up to Help Trubion Advance Early-Stage Anticancer Agent with a $20M Fee
Cancer
Researchers Find Gene Silenced Early in the Development of Chronic Lymphocytic Leukemia
Industry News
BMS to Shell Out $2.4B for Medarex
Insights
Decoding Cell Communication
Insights
Tough Times Ratchet Up Need for Partners
Cancer
High Enzyme Levels May Indicate That Chronic Lymphocytic Leukemia Will Be Aggressive
Cancer
Genzyme Acquires MS and CLL Therapy as well as Two More Oncology Products from Bayer
News
Merck Serono Gains Rights to Ambrx’ Preclinical MS Therapy
1
...
6
7
8
Page 7 of 8
Scroll Up
Scroll Up
